研报 | A股入摩7月表现回顾与展望

wechat omage

 

北上资金成为MSCI标的中国A股的主要购买者,并对个别股增持

中国股票尤其是中概股对新兴市场指数影响进一步加大

北上资金推动个别板块涨幅

北京时间8月14日凌晨,MSCI明晟公司发布了2018年8月指数评估报告。报告显示明晟公司将实施将中国A股部分纳入明晟MSCI中国指数的第二步,将纳入因子从2.5%提升至5%,提升后中国A股占明晟新兴市场指数的权重为0.75%。

据路透社估计,追踪MSCI 新兴市场指数的基金规模约为1.9万亿美元,由此估计,预计按今年纳入的5%将带来1215亿人民币增量资金。按照两步走的流程,预计6月和9月分别有约100亿美元(约合人民币689亿)资金流入。

衔接之前辉立证券新加坡(SGPSPL)的A股入摩6月表现回顾,辉立证券新加坡(SGPSPL)将从资金流向和指数及行业表现两个个角度分析自7月份该事件对中国A股市场的影响。

A股入摩7月份表现回顾 – 资金流入情况

 

北向资金7月份净流入284.7亿元人民币,与6月份净流入基本持平。综合6月7月的资金流入,对比之前预测的100亿美元(约合人民币689亿)的资本注入仍有较大差距。

细分来看:

从日流量上看,7月份以来,沪股通有3个交易日出现净流出状态,深股通有6个交易日出现净流出状态。综合沪股通与深股通的日流量,该月北向资金仅有三个交易日出现净流出状态。

     

从个股来看,下表列出了北向资金交易最活跃的前10只股票。其中可以看出,北向资金对包括中国平安(601318),海螺水泥(600585)等7只股票进行了增持。
从增持金额来看,北向资金对中国平安(601318)的增持金额最大,7月买入中国平安(601318)43.6亿元,占7月份总北向资金净流入的15.32%。

10只月交易活跃股票中,北向资金对中国平安(601318),海螺水泥(600585),伊利股份(600887),招商银行(600036),宝钢股份(600019),贵州茅台(600519),上海机场(600009)进行增持,资金净流入超99亿元,占7月资金总流入的34.77%。

从行业来看,7月份234只MSCI 新兴市场指数标的中国A股对应的11个行业中仅有3个行业保持资金流入,资金流入最多的板块为金融板块,净流入33.9亿元。

综合个股资金流入与板块流入,7月北向资金向属于金融板块的中国平安(601318)净注入43.62亿元,对于该个股注入的资金已经超过板块整体净流入。同月中国平安(601318)资金净流入达15.6亿元,海螺水泥(600585)资金净流入2.7亿元,伊利股份(600887)资金近流入0.1亿元,对比北上资金的净注入,可以看出北向资金已经成为MSCI标的股的主要购买者,对个别股或者板块权重加大。

 

A股入摩7月份表现回顾 – 指数及行业表现

指数表现:

7月份MSCI 新兴市场指数结束连续5个月的跌势,较6月份上涨1.9%。同期,上证指数7月上涨2.95%,MSCI新兴市场指数中6只高权重中概股中,腾讯(0700)下跌9.8%,阿里巴巴(BABA)微涨0.92%,建设银行(0939)涨3.04%,百度(BIDU)涨1.72%,中国移动(0941)涨1.57%,工商银行(1398)涨4.22%。

尽管中国A股在MSCI 新兴市场指数中的权重仅为0.4%,但是中概股与红筹股在该指数中的比重总和为30.7%,仅腾讯(0700)与阿里巴巴(BABA)两只股票的权重和已超过8%,为MSCI新兴市场指数中权重最大的前两只股票。

如下图所示,7月份由于占新兴市场指数30.7%权重的中概股表现不佳,对新兴市场指数的上扬有所拖累,影响了大约3%的增幅,(6月份不到1%的影响)。对于跟踪MSCI新兴市场指数的投资者,需要更加关注中概股的行情。有需要的客户可以关注辉立资本新加坡(SGPSPL)获得中概股的最新资讯与研报。

行业表现:

7月份,234支MSCI 标的股对应的11个行业涨跌不一,其中公共事业(代表股:华能国际(600011)),工业(代表股:中国交建(601800)),材料(代表股:海螺水泥(600585)),金融(代表股:中国平安(601318))4个行业的涨幅均超过5%,跑赢同期大盘。

比较北向资金对于该类板块的资金流入,以金融板块和材料板块为例,北向资金7月份向中国平安(601318)注入43亿元,中国平安7月净注入15亿元,涨幅达5.2%,为金融板块贡献大约0.4%(市值加权)的涨幅。

同样是北向资金增持的海螺水泥(600585),七月北向资金向海螺水泥净注入16亿元,海螺水泥7月净注入2.7亿元,涨幅达15.1%,为材料板块贡献2.2%(市值加权)的涨幅。

由此可见,北向资金的注入很大程度上提振了MSCI标的对应行业的股价增长。


 

展望

尽管中国A股仅占新兴市场指数权重的0.39%,但是由于中国股市与中概股(美国,香港)的行情有很大的联动性,同时对台湾市场和周边国家产生一定的影响,因此我们可以看出MSCI新兴市场指数和上证指数的相关性越来越高。

中国A股从部分纳入到全面纳入是一个长期过程,不会一蹴而就。对比来看,韩国和中国台湾从初步纳入到最终全面纳入分别经历了 6 年和 9 年。

对此,摩根士丹利资本国际(MSCI)表示,进一步加入将受到中国政府是否放松对其资本市场的管制的影响,包括开放国外投资者进入市场,在交易停牌方面取得持续进展,以及进一步放宽对与指数相关的投资工具的限制等。

而随着中国A股在MSCI新兴市场指数中纳入因子的不断提高,如果将中国A股以100%的纳入因子完全纳入,中国A股的权重将达到18%,以目前追踪MSCI新兴市场指数的基金规模计算,将会有约3000亿美元的资金进入中国内地市场。

目前,全球约有1.9万亿美元资产更总新兴市场指数,其中很多以交易所基金(ETF)的形式来跟踪新兴市场指数。其中,规模最大几只基金的有iShares MSCI Emerging Markets ETF (EEM),UltraShort MSCI Emerging Markets(EEV)。

除此之外,国内外有数支交易所基金追踪MSCI中国A股国际指数(MSCI China A International),相关基金有MSCI 中国ETF,KraneShares Bosera MSCI China A Share ETF等。

辉立证券可以交易全球各地上市的3000多种ETF,同时您可以通过便捷的ETF搜索过滤系统根据费用比率、股息收入和市场表现等进行搜索比较。同时辉立证券会定期举办相关研讨会,有需求的客户可以在辉立证券新加坡(SGPSPL)留言咨询。

 

关键字:新加坡股票研报,新加坡股,新加坡研报,新加坡账户,交易新加坡股票,新加坡股票开户,免费开户,在线开设新加坡股票开户,新加坡证券,新加坡券商,投资组合

联系我们开设账户

需要帮助吗?请分享您的详细资料,我们会给您答复。

IMPORTANT INFORMATION

This material is provided by Phillip Capital Management (S) Ltd (“PCM”) for general information only and does not constitute a recommendation, an offer to sell, or a solicitation of any offer to invest in any of the exchange-traded fund (“ETF”) or the unit trust (“Products”) mentioned herein. It does not have any regard to your specific investment objectives, financial situation and any of your particular needs. You should read the Prospectus and the accompanying Product Highlights Sheet (“PHS”) for key features, key risks and other important information of the Products and obtain advice from a financial adviser (“FA“) pursuant to a separate engagement before making a commitment to invest in the Products. In the event that you choose not to obtain advice from a FA, you should assess whether the Products are suitable for you before proceeding to invest. A copy of the Prospectus and PHS are available from PCM, any of its Participating Dealers (“PDs“) for the ETF, or any of its authorised distributors for the unit trust managed by PCM.  

An ETF is not like a typical unit trust as the units of the ETF (the “Units“) are to be listed and traded like any share on the Singapore Exchange Securities Trading Limited (“SGX-ST”). Listing on the SGX-ST does not guarantee a liquid market for the Units which may be traded at prices above or below its NAV or may be suspended or delisted. Investors may buy or sell the Units on SGX-ST when it is listed. Investors cannot create or redeem Units directly with PCM and have no rights to request PCM to redeem or purchase their Units. Creation and redemption of Units are through PDs if investors are clients of the PDs, who have no obligation to agree to create or redeem Units on behalf of any investor and may impose terms and conditions in connection with such creation or redemption orders. Please refer to the Prospectus of the ETF for more details.  

Investments are subject to investment risks including the possible loss of the principal amount invested. The purchase of a unit in a fund is not the same as placing your money on deposit with a bank or deposit-taking company. There is no guarantee as to the amount of capital invested or return received. The value of the units and the income accruing to the units may fall or rise. Past performance is not necessarily indicative of the future or likely performance of the Products. There can be no assurance that investment objectives will be achieved.  

Where applicable, fund(s) may invest in financial derivatives and/or participate in securities lending and repurchase transactions for the purpose of hedging and/or efficient portfolio management, subject to the relevant regulatory requirements. PCM reserves the discretion to determine if currency exposure should be hedged actively, passively or not at all, in the best interest of the Products.  

The regular dividend distributions, out of either income and/or capital, are not guaranteed and subject to PCM’s discretion. Past payout yields and payments do not represent future payout yields and payments. Such dividend distributions will reduce the available capital for reinvestment and may result in an immediate decrease in the net asset value (“NAV”) of the Products. Please refer to <www.phillipfunds.com> for more information in relation to the dividend distributions.  

The information provided herein may be obtained or compiled from public and/or third party sources that PCM has no reason to believe are unreliable. Any opinion or view herein is an expression of belief of the individual author or the indicated source (as applicable) only. PCM makes no representation or warranty that such information is accurate, complete, verified or should be relied upon as such. The information does not constitute, and should not be used as a substitute for tax, legal or investment advice.  

The information herein are not for any person in any jurisdiction or country where such distribution or availability for use would contravene any applicable law or regulation or would subject PCM to any registration or licensing requirement in such jurisdiction or country. The Products is not offered to U.S. Persons. PhillipCapital Group of Companies, including PCM, their affiliates and/or their officers, directors and/or employees may own or have positions in the Products. Any member of the PhillipCapital Group of Companies may have acted upon or used the information, analyses and opinions herein before they have been published. 

This advertisement has not been reviewed by the Monetary Authority of Singapore.  

 

Phillip Capital Management (S) Ltd (Co. Reg. No. 199905233W)  
250 North Bridge Road #06-00, Raffles City Tower ,Singapore 179101 
Tel: (65) 6230 8133 Fax: (65) 65383066 www.phillipfunds.com